Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer

Vascular endothelial growth factor (VEGF) gene is an important angiogenesis regulator related to cancer development and progression. We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican subjects, to contribute to knowledge of VEGF role in genetic epidemiolog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer biomarkers : section A of Disease markers 2013-01, Vol.13 (4), p.235-241
Hauptverfasser: Martinez-Fierro, M L, Garza-Veloz, I, Rojas-Martinez, A, Ortiz-Lopez, R, Castruita-de la Rosa, C, Ortiz-Castro, Y, Lazalde-Ramos, B P, Cervantes-Villagrana, A R, Castañeda-Lopez, M E, Gomez-Guerra, L, Delgado-Enciso, I, Martinez-Torres, A A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 241
container_issue 4
container_start_page 235
container_title Cancer biomarkers : section A of Disease markers
container_volume 13
creator Martinez-Fierro, M L
Garza-Veloz, I
Rojas-Martinez, A
Ortiz-Lopez, R
Castruita-de la Rosa, C
Ortiz-Castro, Y
Lazalde-Ramos, B P
Cervantes-Villagrana, A R
Castañeda-Lopez, M E
Gomez-Guerra, L
Delgado-Enciso, I
Martinez-Torres, A A
description Vascular endothelial growth factor (VEGF) gene is an important angiogenesis regulator related to cancer development and progression. We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican subjects, to contribute to knowledge of VEGF role in genetic epidemiology of prostate cancer (PCa). The aim of this study was to evaluate the association between -2578 C/A VEGF variant and PCa in Mexican population. A total of 249 men (77 PCa cases and 172 controls) from the Northwestern region of Mexico were screened for the -2578 C/A VEGF variant. The polymorphism was determined by polymerase chain reaction-based restriction analysis. Genotype frequencies for C/C, C/A, and A/A, were 0.48, 0.49, 0.03 for cases and 0.41, 0.45, 0.14 for controls respectively. Genotype A/A of -2578 VEGF variant reduces the risk of PCa in an 84% among studied population (Odds Ratio 0.16; 95% CI: 0.04-0.71, P=0.007). C/C carriers showed an increased PCa risk of 6.1 times among the study population. Inheritance of -2578 A/A genotype of VEGF gene may modify PCa susceptibility risk in Mexican population.
doi_str_mv 10.3233/CBM-130348
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1459558484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1459558484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c323t-1bae16687d1ee120d71851a72cac11ae1911315f76104e1336437a915ce31bc83</originalsourceid><addsrcrecordid>eNo9kEFPAjEQhRujEUQv_gDTI5qsdLYt2z0qATTB6EG9bobuIGuWXWwLxH9vDehpJpk3b-Z9jF2CuJWplIPR_VMCUkhljlgXTKYTo_P0OPY6U4kALTvszPtPIZSEND9lnVSlSmijuqx-aX0Vqi1x9L61FYaqbficwo6o4Vv0dlOj49SUbVhSXWHNP1y7C0u-QBtax_vv4-nkmiepzgwfDe7ijquwCRybkq9d6wMG4hYbS-6cnSyw9nRxqD32Nhm_jh6S2fP0cXQ3S2zMExKYI8FwaLISiCAVZQZGA2apRQsQZzmABL3IhiAUgZRDJTPMQVuSMLdG9lh_7xvvf23Ih2JVeUt1jQ21G1-A0rmO8Y2K0pu91MZXvaNFsXbVCt13AaL4pVtEusWebhRfHXw38xWV_9I_nPIHltZy8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1459558484</pqid></control><display><type>article</type><title>Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer</title><source>MEDLINE</source><source>Sage Journals GOLD Open Access 2024</source><creator>Martinez-Fierro, M L ; Garza-Veloz, I ; Rojas-Martinez, A ; Ortiz-Lopez, R ; Castruita-de la Rosa, C ; Ortiz-Castro, Y ; Lazalde-Ramos, B P ; Cervantes-Villagrana, A R ; Castañeda-Lopez, M E ; Gomez-Guerra, L ; Delgado-Enciso, I ; Martinez-Torres, A A</creator><creatorcontrib>Martinez-Fierro, M L ; Garza-Veloz, I ; Rojas-Martinez, A ; Ortiz-Lopez, R ; Castruita-de la Rosa, C ; Ortiz-Castro, Y ; Lazalde-Ramos, B P ; Cervantes-Villagrana, A R ; Castañeda-Lopez, M E ; Gomez-Guerra, L ; Delgado-Enciso, I ; Martinez-Torres, A A</creatorcontrib><description>Vascular endothelial growth factor (VEGF) gene is an important angiogenesis regulator related to cancer development and progression. We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican subjects, to contribute to knowledge of VEGF role in genetic epidemiology of prostate cancer (PCa). The aim of this study was to evaluate the association between -2578 C/A VEGF variant and PCa in Mexican population. A total of 249 men (77 PCa cases and 172 controls) from the Northwestern region of Mexico were screened for the -2578 C/A VEGF variant. The polymorphism was determined by polymerase chain reaction-based restriction analysis. Genotype frequencies for C/C, C/A, and A/A, were 0.48, 0.49, 0.03 for cases and 0.41, 0.45, 0.14 for controls respectively. Genotype A/A of -2578 VEGF variant reduces the risk of PCa in an 84% among studied population (Odds Ratio 0.16; 95% CI: 0.04-0.71, P=0.007). C/C carriers showed an increased PCa risk of 6.1 times among the study population. Inheritance of -2578 A/A genotype of VEGF gene may modify PCa susceptibility risk in Mexican population.</description><identifier>ISSN: 1574-0153</identifier><identifier>EISSN: 1875-8592</identifier><identifier>DOI: 10.3233/CBM-130348</identifier><identifier>PMID: 24240584</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Age Factors ; Aged ; Aged, 80 and over ; Alleles ; Case-Control Studies ; Gene Frequency ; Genetic Association Studies ; Genetic Predisposition to Disease ; Genotype ; Humans ; Inheritance Patterns ; Male ; Mexico ; Middle Aged ; Neoplasm Grading ; Odds Ratio ; Polymorphism, Single Nucleotide ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - pathology ; Retrospective Studies ; Vascular Endothelial Growth Factor A - genetics</subject><ispartof>Cancer biomarkers : section A of Disease markers, 2013-01, Vol.13 (4), p.235-241</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c323t-1bae16687d1ee120d71851a72cac11ae1911315f76104e1336437a915ce31bc83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27913,27914</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24240584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinez-Fierro, M L</creatorcontrib><creatorcontrib>Garza-Veloz, I</creatorcontrib><creatorcontrib>Rojas-Martinez, A</creatorcontrib><creatorcontrib>Ortiz-Lopez, R</creatorcontrib><creatorcontrib>Castruita-de la Rosa, C</creatorcontrib><creatorcontrib>Ortiz-Castro, Y</creatorcontrib><creatorcontrib>Lazalde-Ramos, B P</creatorcontrib><creatorcontrib>Cervantes-Villagrana, A R</creatorcontrib><creatorcontrib>Castañeda-Lopez, M E</creatorcontrib><creatorcontrib>Gomez-Guerra, L</creatorcontrib><creatorcontrib>Delgado-Enciso, I</creatorcontrib><creatorcontrib>Martinez-Torres, A A</creatorcontrib><title>Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer</title><title>Cancer biomarkers : section A of Disease markers</title><addtitle>Cancer Biomark</addtitle><description>Vascular endothelial growth factor (VEGF) gene is an important angiogenesis regulator related to cancer development and progression. We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican subjects, to contribute to knowledge of VEGF role in genetic epidemiology of prostate cancer (PCa). The aim of this study was to evaluate the association between -2578 C/A VEGF variant and PCa in Mexican population. A total of 249 men (77 PCa cases and 172 controls) from the Northwestern region of Mexico were screened for the -2578 C/A VEGF variant. The polymorphism was determined by polymerase chain reaction-based restriction analysis. Genotype frequencies for C/C, C/A, and A/A, were 0.48, 0.49, 0.03 for cases and 0.41, 0.45, 0.14 for controls respectively. Genotype A/A of -2578 VEGF variant reduces the risk of PCa in an 84% among studied population (Odds Ratio 0.16; 95% CI: 0.04-0.71, P=0.007). C/C carriers showed an increased PCa risk of 6.1 times among the study population. Inheritance of -2578 A/A genotype of VEGF gene may modify PCa susceptibility risk in Mexican population.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alleles</subject><subject>Case-Control Studies</subject><subject>Gene Frequency</subject><subject>Genetic Association Studies</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Humans</subject><subject>Inheritance Patterns</subject><subject>Male</subject><subject>Mexico</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Odds Ratio</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - blood</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Retrospective Studies</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><issn>1574-0153</issn><issn>1875-8592</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEFPAjEQhRujEUQv_gDTI5qsdLYt2z0qATTB6EG9bobuIGuWXWwLxH9vDehpJpk3b-Z9jF2CuJWplIPR_VMCUkhljlgXTKYTo_P0OPY6U4kALTvszPtPIZSEND9lnVSlSmijuqx-aX0Vqi1x9L61FYaqbficwo6o4Vv0dlOj49SUbVhSXWHNP1y7C0u-QBtax_vv4-nkmiepzgwfDe7ijquwCRybkq9d6wMG4hYbS-6cnSyw9nRxqD32Nhm_jh6S2fP0cXQ3S2zMExKYI8FwaLISiCAVZQZGA2apRQsQZzmABL3IhiAUgZRDJTPMQVuSMLdG9lh_7xvvf23Ih2JVeUt1jQ21G1-A0rmO8Y2K0pu91MZXvaNFsXbVCt13AaL4pVtEusWebhRfHXw38xWV_9I_nPIHltZy8w</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Martinez-Fierro, M L</creator><creator>Garza-Veloz, I</creator><creator>Rojas-Martinez, A</creator><creator>Ortiz-Lopez, R</creator><creator>Castruita-de la Rosa, C</creator><creator>Ortiz-Castro, Y</creator><creator>Lazalde-Ramos, B P</creator><creator>Cervantes-Villagrana, A R</creator><creator>Castañeda-Lopez, M E</creator><creator>Gomez-Guerra, L</creator><creator>Delgado-Enciso, I</creator><creator>Martinez-Torres, A A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130101</creationdate><title>Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer</title><author>Martinez-Fierro, M L ; Garza-Veloz, I ; Rojas-Martinez, A ; Ortiz-Lopez, R ; Castruita-de la Rosa, C ; Ortiz-Castro, Y ; Lazalde-Ramos, B P ; Cervantes-Villagrana, A R ; Castañeda-Lopez, M E ; Gomez-Guerra, L ; Delgado-Enciso, I ; Martinez-Torres, A A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c323t-1bae16687d1ee120d71851a72cac11ae1911315f76104e1336437a915ce31bc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alleles</topic><topic>Case-Control Studies</topic><topic>Gene Frequency</topic><topic>Genetic Association Studies</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Humans</topic><topic>Inheritance Patterns</topic><topic>Male</topic><topic>Mexico</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Odds Ratio</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - blood</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Retrospective Studies</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martinez-Fierro, M L</creatorcontrib><creatorcontrib>Garza-Veloz, I</creatorcontrib><creatorcontrib>Rojas-Martinez, A</creatorcontrib><creatorcontrib>Ortiz-Lopez, R</creatorcontrib><creatorcontrib>Castruita-de la Rosa, C</creatorcontrib><creatorcontrib>Ortiz-Castro, Y</creatorcontrib><creatorcontrib>Lazalde-Ramos, B P</creatorcontrib><creatorcontrib>Cervantes-Villagrana, A R</creatorcontrib><creatorcontrib>Castañeda-Lopez, M E</creatorcontrib><creatorcontrib>Gomez-Guerra, L</creatorcontrib><creatorcontrib>Delgado-Enciso, I</creatorcontrib><creatorcontrib>Martinez-Torres, A A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer biomarkers : section A of Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinez-Fierro, M L</au><au>Garza-Veloz, I</au><au>Rojas-Martinez, A</au><au>Ortiz-Lopez, R</au><au>Castruita-de la Rosa, C</au><au>Ortiz-Castro, Y</au><au>Lazalde-Ramos, B P</au><au>Cervantes-Villagrana, A R</au><au>Castañeda-Lopez, M E</au><au>Gomez-Guerra, L</au><au>Delgado-Enciso, I</au><au>Martinez-Torres, A A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer</atitle><jtitle>Cancer biomarkers : section A of Disease markers</jtitle><addtitle>Cancer Biomark</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>13</volume><issue>4</issue><spage>235</spage><epage>241</epage><pages>235-241</pages><issn>1574-0153</issn><eissn>1875-8592</eissn><abstract>Vascular endothelial growth factor (VEGF) gene is an important angiogenesis regulator related to cancer development and progression. We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican subjects, to contribute to knowledge of VEGF role in genetic epidemiology of prostate cancer (PCa). The aim of this study was to evaluate the association between -2578 C/A VEGF variant and PCa in Mexican population. A total of 249 men (77 PCa cases and 172 controls) from the Northwestern region of Mexico were screened for the -2578 C/A VEGF variant. The polymorphism was determined by polymerase chain reaction-based restriction analysis. Genotype frequencies for C/C, C/A, and A/A, were 0.48, 0.49, 0.03 for cases and 0.41, 0.45, 0.14 for controls respectively. Genotype A/A of -2578 VEGF variant reduces the risk of PCa in an 84% among studied population (Odds Ratio 0.16; 95% CI: 0.04-0.71, P=0.007). C/C carriers showed an increased PCa risk of 6.1 times among the study population. Inheritance of -2578 A/A genotype of VEGF gene may modify PCa susceptibility risk in Mexican population.</abstract><cop>Netherlands</cop><pmid>24240584</pmid><doi>10.3233/CBM-130348</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1574-0153
ispartof Cancer biomarkers : section A of Disease markers, 2013-01, Vol.13 (4), p.235-241
issn 1574-0153
1875-8592
language eng
recordid cdi_proquest_miscellaneous_1459558484
source MEDLINE; Sage Journals GOLD Open Access 2024
subjects Age Factors
Aged
Aged, 80 and over
Alleles
Case-Control Studies
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Genotype
Humans
Inheritance Patterns
Male
Mexico
Middle Aged
Neoplasm Grading
Odds Ratio
Polymorphism, Single Nucleotide
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood
Prostatic Neoplasms - genetics
Prostatic Neoplasms - pathology
Retrospective Studies
Vascular Endothelial Growth Factor A - genetics
title Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T10%3A08%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Positive%20association%20between%20vascular%20endothelial%20growth%20factor%20(VEGF)%20-2578%20C/A%20variant%20and%20prostate%20cancer&rft.jtitle=Cancer%20biomarkers%20:%20section%20A%20of%20Disease%20markers&rft.au=Martinez-Fierro,%20M%20L&rft.date=2013-01-01&rft.volume=13&rft.issue=4&rft.spage=235&rft.epage=241&rft.pages=235-241&rft.issn=1574-0153&rft.eissn=1875-8592&rft_id=info:doi/10.3233/CBM-130348&rft_dat=%3Cproquest_cross%3E1459558484%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1459558484&rft_id=info:pmid/24240584&rfr_iscdi=true